glp-1 jumpstart guide 💡Read the full here: https://bit.ly/4wWgixE Considering a GLP-1s medication? These medications can help manage type 2 diabetes and obesity. These questions can help you start the conversation with your doctor to GLP-1 is one of the

The GLP-1 receptor agonist market is experiencing significant growth, driven by the increasing prevalence of type 2 diabetes and obesity, and the high...

We also present practical implications of these glucose-lowering agents for reducing the risk of adverse cardiovascular events and progressive renal comorbidity in patients with T2D and CVD.

An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...

Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.